This study aimed to re-evaluate the use of iRGD peptide, demonstrated that it enhanced the accumulation and therapeutic efficacy of drugs in the NSCLC xenograft established with A549 cell line that showed high expression of αvβ3, αvβ5 and NRP-1. Here, NRP1 is linked to non-small cell lung carcinoma.